HilleVax, Inc. (HLVX)
NASDAQ: HLVX · Real-Time Price · USD
1.910
-0.050 (-2.55%)
May 5, 2025, 4:00 PM EDT - Market closed
HilleVax Market Cap
HilleVax has a market cap or net worth of $94.02 million as of May 5, 2025. Its market cap has decreased by -84.42% in one year.
Market Cap
94.02M
Enterprise Value
-53.40M
1-Year Change
-84.42%
Ranking
Category
Stock Price
$1.91
Market Cap Chart
Since the IPO on April 29, 2022, HilleVax's market cap has decreased from $538.26M to $94.02M, a decrease of -82.53%. That is a compound annual growth rate of -43.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 2, 2025 | 96.48M | -3.37% |
| Dec 31, 2024 | 99.85M | -86.63% |
| Dec 29, 2023 | 746.58M | 25.20% |
| Dec 30, 2022 | 596.32M | 10.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 739.39B |
| Johnson & Johnson | 375.64B |
| UnitedHealth Group | 364.02B |
| AbbVie | 351.09B |
| Novo Nordisk | 307.48B |
| Abbott Laboratories | 231.09B |
| Novartis AG | 223.50B |
| AstraZeneca | 221.69B |